Latest Cyclacel Pharmaceuticals (CYCCP) Headlines
Post# of 5
Posted On: 03/13/2014 7:27:05 AM
Latest Cyclacel Pharmaceuticals (CYCCP) Headlines
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - 26 mins ago
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce fourth quarter and full year 2013 financial results on Tuesday, March 25, 2014. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2013 Financial Results
GlobeNewswire - 26 mins ago
Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing oral therapies that target the various phases of cell cycle control for the treatment of cancer and other serious disorders, will announce fourth quarter and full year 2013 financial results on Tuesday, March 25, 2014. The Company will host a conference call and live webcast at 4:30 pm Eastern time on the same day.
(0)
(0)Cyclacel Pharmaceuticals (CYCCP) Stock Research Links
Scroll down for more posts ▼